Creatine Activity as a Neuromodulator in the Central Nervous System - PMC
Paxil (paroxetine), a selective serotonin reuptake inhibitor (SSRI), and creatine have different pharmacological profiles, but recent research highlights potential synergies and clinical considerations when they are used together. Therapeutic Augmentation and Synergy Paxil And Creatine
Recent clinical studies suggest that adding creatine to SSRI therapy may enhance and accelerate treatment response for depression. Creatine Activity as a Neuromodulator in the Central
: Depression is often linked to impaired brain bioenergetics. Creatine helps restore these cellular energy levels by facilitating the recycling of adenosine triphosphate (ATP), which may directly support mood regulation. Creatine helps restore these cellular energy levels by
: In a double-blind trial involving women with major depressive disorder, creatine augmentation (5 g/day) of an SSRI led to significantly greater improvements in Hamilton Depression Rating Scale (HAM-D) scores as early as week 2 compared to placebo.
While generally considered safe, certain physiological interactions warrant professional medical oversight.